The Philippine outlet covers regulators' worries about unapproved weight loss drugs, with retatrutide named among them. Tap through for the details.
Recap by typeshit. Full story at Philstar Life.
She walks through the phase 3 data, including knee osteoarthritis results, and explains why she calls online reta vials a gamble.
In a Healio Eye-Mail brief, she gives her view on a review of a possible link between GLP-1 medications and NAION, a type of optic nerve damage.
Retatrutide is still in clinical trials, yet people are discussing using it online. A new analysis takes a first systematic look at the side effects they describe.
The Atlanta Journal-Constitution looks at how an unapproved weight loss drug is being sold through an underground market across Georgia.
Ashlee Amborn says she conceived a month into GLP-1 use. A review hints at a link in women with obesity and PMOS, but doctors say stop the drug before trying.
A market update credits new generics and steady prices for the rise in sales value, with Eli Lilly's tirzepatide featured in the numbers.
Loading…